Most Recent Articles by Brandon May
In patients with primary antiphospholipid syndrome, the presence of phosphatidylserine/prothrombin complex antibodies is associated with Raynaud phenomenon and migraine.
Few patients with cancer experienced a flare of their pre-existing rheumatic disease or an immune-related adverse effect.
Hospitals participating in the 340B Drug Pricing Program have increased outpatient provision of parenteral drugs in hematology-oncology and ophthalmology.
Patients with end-stage knee or hip osteoarthritis may often experience neuropathic pain, particularly at rest.
For patients with rheumatoid arthritis, abatacept conferred a greater reduction in CVD risk compared with TNF inihibitors.
More Articles by Brandon May
Rheumatology Advisor Articles
- Large Vessel Vasculitis Imaging: Recommendations for Clinical Practice
- Salivary Gland Ultrasound Scores Improved With Rituximab in Primary Sjogren's Syndrome
- Joint Replacement Rates in OA With Diabetes: Effects of COX-2 Inhibitors Plus Metformin
- Imaging Changes Examined in Tocilizumab-Treated Polymyalgia Rheumatica
- Scleroderma and Breast Cancer: Examining Outcomes of Radiation Therapy
- FDA Advises Recall: Limbrel May Be Linked to Drug-Induced Liver Injury
- Allopurinol Use May Lower Risk for Peripheral Arterial Disease
- Managing Treatment Nonadherence in Rheumatic Diseases
- Optimal Fibromyalgia Management Includes Individualized, Multimodal Therapy
- Risk for COPD, Asthma Among Women With Rheumatoid Arthritis: Nurses' Health Study
- Raynaud Phenomenon, Migraine Linked to aPS/PT Antibodies in Primary Antiphospholipid Syndrome
- Treating Violence as a Contagious Health Problem
- Factors of Plasma Ropivacaine Concentrations After Local Infiltration Analgesia in TKA
- Anti-CCP Positivity Associated With Increased Risk of Major Fracture in RA
- Then and Now: The Crisis of Physician Suicides